Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
- PMID: 32849623
- PMCID: PMC7427491
- DOI: 10.3389/fimmu.2020.01748
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
Abstract
Elderly individuals are the most susceptible to an aggressive form of coronavirus disease (COVID-19), caused by SARS-CoV-2. The remodeling of immune response that is observed among the elderly could explain, at least in part, the age gradient in lethality of COVID-19. In this review, we will discuss the phenomenon of immunosenescence, which entails changes that occur in both innate and adaptive immunity with aging. Furthermore, we will discuss inflamm-aging, a low-grade inflammatory state triggered by continuous antigenic stimulation, which may ultimately increase all-cause mortality. In general, the elderly are less capable of responding to neo-antigens, because of lower naïve T cell frequency. Furthermore, they have an expansion of memory T cells with a shrinkage of the T cell diversity repertoire. When infected by SARS-CoV-2, young people present with a milder disease as they frequently clear the virus through an efficient adaptive immune response. Indeed, antibody-secreting cells and follicular helper T cells are thought to be effectively activated in young patients that present a favorable prognosis. In contrast, the elderly are more prone to an uncontrolled activation of innate immune response that leads to cytokine release syndrome and tissue damage. The failure to trigger an effective adaptive immune response in combination with a higher pro-inflammatory tonus may explain why the elderly do not appropriately control viral replication and the potential clinical consequences triggered by a cytokine storm, endothelial injury, and disseminated organ injury. Enhancing the efficacy of the adaptive immune response may be an important issue both for infection resolution as well as for the appropriate generation of immunity upon vaccination, while inhibiting inflamm-aging will likely emerge as a potential complementary therapeutic approach in the management of patients with severe COVID-19.
Keywords: COVID-19; SARS-CoV-2; immunopathogenesis; immunosenescence; inflammaging.
Copyright © 2020 Cunha, Perazzio, Azzi, Cravedi and Riella.
Figures
Similar articles
-
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.J Immunol. 2020 Nov 15;205(10):2566-2575. doi: 10.4049/jimmunol.2000892. Epub 2020 Sep 21. J Immunol. 2020. PMID: 32958687 Review.
-
Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.Rev Med Virol. 2020 Sep;30(5):e2144. doi: 10.1002/rmv.2144. Epub 2020 Jul 15. Rev Med Virol. 2020. PMID: 32671966 Free PMC article. Review.
-
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2. J Immunol. 2020. PMID: 32878912 Free PMC article.
-
Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.J Transl Med. 2020 May 12;18(1):196. doi: 10.1186/s12967-020-02363-3. J Transl Med. 2020. PMID: 32398026 Free PMC article.
-
Age-Related Differences in Immunological Responses to SARS-CoV-2.J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3251-3258. doi: 10.1016/j.jaip.2020.08.026. Epub 2020 Aug 27. J Allergy Clin Immunol Pract. 2020. PMID: 32861856 Free PMC article. Review.
Cited by
-
Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine.Immun Ageing. 2024 Jan 27;21(1):11. doi: 10.1186/s12979-023-00408-x. Immun Ageing. 2024. PMID: 38280989 Free PMC article.
-
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.Front Immunol. 2022 Mar 25;13:842439. doi: 10.3389/fimmu.2022.842439. eCollection 2022. Front Immunol. 2022. PMID: 35401516 Free PMC article.
-
Heterozygous OT-I mice reveal that antigen-specific CD8+ T cells shift from apoptotic to necrotic killers in the elderly.Aging Cell. 2023 Jun;22(6):e13824. doi: 10.1111/acel.13824. Epub 2023 Mar 22. Aging Cell. 2023. PMID: 36947105 Free PMC article.
-
Causal pathway from telomere length to occurrence and 28-day mortality of sepsis: an observational and mendelian randomization study.Aging (Albany NY). 2023 Aug 4;15(15):7727-7740. doi: 10.18632/aging.204937. Epub 2023 Aug 4. Aging (Albany NY). 2023. PMID: 37543429 Free PMC article.
-
Cell nonautonomous roles of NHR-49 in promoting longevity and innate immunity.Aging Cell. 2021 Jul;20(7):e13413. doi: 10.1111/acel.13413. Epub 2021 Jun 22. Aging Cell. 2021. PMID: 34156142 Free PMC article.
References
-
- NIH Coronavirus (COVID-19). National Institutes of Health; (2020). Available online at: https://www.nih.gov/health-information/coronavirus (accessed April 19, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous